Event Brief
Jan 13, 2026 at 1:05 AM ET
China’s SciNeuro, Novartis Sign $1.7B Alzheimer’s Deal
By The BriefBrief
SciNeuro and Novartis partner to develop Alzheimer’s drugs in a $1.7 billion deal, enhancing treatment hopes.
WHO: SciNeuro Pharmaceuticals, Novartis
WHAT: Licensing deal for Alzheimer’s drug development
WHEN: Jan 12, 2026 at 7:00 PM ET
WHERE: China, Switzerland
WHY: To develop and commercialize Alzheimer’s treatments
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21439 of 21439
Same format. Every time.
Continue reading — sign in or create a free account with
